Structures by: Ertan R.
Total: 11
C20H12Cl1N1O4S1
C20H12Cl1N1O4S1
Acta Crystallographica Section E (2005) 61, 4 o870-o872
a=8.7819(8)Å b=10.2641(7)Å c=10.4074(12)Å
α=112.034(8)° β=98.297(8)° γ=94.009(7)°
3-Methyl-5-(4-oxo-4H-chromen-3-ylmethylene)-1,3-thiazolidine-2,4-dione
C14H9N1O4S1
Acta Crystallographica Section E (2006) 62, 4 o1471-o1473
a=5.5926(3)Å b=27.0630(2)Å c=7.6829(4)Å
α=90° β=92.439(4)° γ=90°
C28H27NO6
C28H27NO6
Acta Crystallographica Section C (1999) 55, 4 678-680
a=9.9152(6)Å b=11.0521(7)Å c=13.7630(10)Å
α=69.600(5)° β=73.969(6)° γ=65.035(5)°
C20H16O6
C20H16O6
Acta Crystallographica Section C (1997) 53, 12 1981-1983
a=11.0244(10)Å b=7.5621(10)Å c=19.9172(10)Å
α=90.0° β=91.407(4)° γ=90.0°
C15H12O3
C15H12O3
Acta Crystallographica Section C (1995) 51, 9 1880-1883
a=5.333(2)Å b=23.891(6)Å c=9.876(2)Å
α=90° β=101.68(2)° γ=90°
C19H18O5
C19H18O5
Acta Crystallographica Section C (1995) 51, 9 1880-1883
a=7.238(3)Å b=7.822(3)Å c=29.518(13)Å
α=90° β=90.48(4)° γ=90°
7-Hydroxy-4'-methoxy Flavanone
C16H14O4
Acta Crystallographica Section C (1995) 51, 7 1442-1444
a=12.841(7)Å b=8.113(4)Å c=14.219(7)Å
α=90.00° β=115.89(4)° γ=90.00°
3-Ethyl-5-(4-oxochroman-3-ylmethylene)-1,3-imidazolidine-2,4-dione
C15H12N2O4
Acta Crystallographica Section E (2007) 63, 1 o184-o185
a=5.3407(4)Å b=10.4070(8)Å c=12.0223(9)Å
α=106.953(6)° β=101.066(6)° γ=92.143(6)°
5-[4-Chloro-2-(4-chlorobenzylsulfanyl)thiazol-5-ylmethylene]-3-(2,4- dichlorobenzyl)thiazolidine-2,4-dione
C21H12Cl4N2O2S3
Acta Crystallographica Section E (2007) 63, 5 o2355-o2356
a=8.0420(7)Å b=14.359(2)Å c=21.2641(15)Å
α=100.386(8)° β=99.594(7)° γ=104.237(10)°
C15H11NO4S
C15H11NO4S
Acta Crystallographica Section C (2000) 56, 4 457-458
a=8.6654(5)Å b=8.7898(6)Å c=10.0105(6)Å
α=98.183(7)° β=112.991(6)° γ=104.673(6)°
4-amino-N-(5-methylisoxazol-3-yl)-N-[(4-oxo-2-phenyl-4H-1-benzopyran-6- yl)methyl]benzensulfonamide
C26H21N3O5S1
Acta Crystallographica Section C (2005) 61, 9 o559-o561
a=8.824(2)Å b=23.183(4)Å c=11.305(3)Å
α=90° β=96.185(2)° γ=90°